TRINSEO PLC (TSE)

IE0000QBK8U7 - Common Stock

3.46  +0.21 (+6.46%)

After market: 3.52 +0.06 (+1.73%)

Fundamental Rating

2

Overall TSE gets a fundamental rating of 2 out of 10. We evaluated TSE against 84 industry peers in the Chemicals industry. TSE has a bad profitability rating. Also its financial health evaluation is rather negative. TSE does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.
TSE had a negative operating cash flow in the past year.
In multiple years TSE reported negative net income over the last 5 years.
Each year in the past 5 years TSE had a positive operating cash flow.

1.2 Ratios

TSE has a Return On Assets of -17.19%. This is amonst the worse of the industry: TSE underperforms 87.06% of its industry peers.
Industry RankSector Rank
ROA -17.19%
ROE N/A
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-4.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TSE has a worse Gross Margin (6.51%) than 85.88% of its industry peers.
TSE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.83%
GM growth 5Y-19.48%

1

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TSE has more shares outstanding
TSE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, TSE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.99, we must say that TSE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.99, TSE is doing worse than 74.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.99
ROIC/WACCN/A
WACC6.24%

2.3 Liquidity

TSE has a Current Ratio of 1.38. This is a normal value and indicates that TSE is financially healthy and should not expect problems in meeting its short term obligations.
TSE has a worse Current ratio (1.38) than 78.82% of its industry peers.
A Quick Ratio of 0.84 indicates that TSE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.84, TSE is doing worse than 78.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.84

3

3. Growth

3.1 Past

The earnings per share for TSE have decreased strongly by -41.02% in the last year.
TSE shows a decrease in Revenue. In the last year, the revenue decreased by -7.45%.
Measured over the past years, TSE shows a decrease in Revenue. The Revenue has been decreasing by -4.48% on average per year.
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.28%
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y10.22%
Revenue growth 5Y-4.48%
Sales Q2Q%-1.29%

3.2 Future

TSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.52% yearly.
Based on estimates for the next years, TSE will show a small growth in Revenue. The Revenue will grow by 2.52% on average per year.
EPS Next Y2.02%
EPS Next 2Y24.35%
EPS Next 3Y24.93%
EPS Next 5Y29.52%
Revenue Next Year-3.12%
Revenue Next 2Y0.79%
Revenue Next 3Y2.52%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TSE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.87

4.3 Compensation for Growth

TSE's earnings are expected to grow with 24.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.35%
EPS Next 3Y24.93%

2

5. Dividend

5.1 Amount

TSE has a Yearly Dividend Yield of 1.10%.
The stock price of TSE dropped by -21.72% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
TSE's Dividend Yield is comparable with the industry average which is at 2.95.
With a Dividend Yield of 1.10, TSE pays less dividend than the S&P500 average, which is at 2.23.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

The dividend of TSE decreases each year by -20.01%.
TSE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-20.01%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of TSE are negative and hence is the payout ratio. TSE will probably not be able to sustain this dividend level.
DP-0.32%
EPS Next 2Y24.35%
EPS Next 3Y24.93%

TRINSEO PLC

NYSE:TSE (11/21/2024, 8:04:00 PM)

After market: 3.52 +0.06 (+1.73%)

3.46

+0.21 (+6.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap122.48M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.19%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 6.51%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.38
Quick Ratio 0.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y2.02%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y10.22%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y